Teladoc Health Inc.

NYSE: TDOC · Real-Time Price · USD
7.50
0.20 (2.74%)
At close: Aug 15, 2025, 10:01 AM

Teladoc Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.57B 2.6B 2.41B 2.03B
Cost of Revenue
751.27M 760.03M 743.99M 650.26M
Gross Profit
1.82B 1.84B 1.66B 1.38B
Operating Income
-1.02B -248.55M 13.2B -238.99M
Interest Income
57.07M 46.78M 12.67M 776K
Pretax Income
-993.65M -219.61M -13.66B -384.66M
Net Income
-1B -220.37M -13.66B -428.79M
Selling & General & Admin
1.35B 1.37B 1.3B 1.11B
Research & Development
307.27M 348.52M 333.63M 311.88M
Other Expenses
1.19B 375.12M 256.03M 204.24M
Operating Expenses
2.84B 2.09B 1.89B 1.62B
Interest Expense
23.8M 22.28M 21.94M 81.14M
Selling & Marketing Expenses
910.78M 902.63M 850.71M 667.31M
Cost & Expenses
3.59B 2.85B 2.63B 2.27B
Income Tax Expense
7.59M 760K -3.81M 44.14M
Shares Outstanding (Basic)
170.56M 162.17M 161.46M 156.94M
Shares Outstanding (Diluted)
170.56M 164.58M 161.46M 156.94M
EPS (Basic)
-5.87 -1.36 -84.6 -2.73
EPS (Diluted)
-5.87 -1.34 -84.6 -2.73
EBITDA
-587.01M 154M -13.38B -84.67M
EBIT
-969.85M -197.33M -13.64B -303.51M
Depreciation & Amortization
382.84M 351.32M 270.64M 219.62M